Literature DB >> 8666328

Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin.

C Dehmlow1, J Erhard, H de Groot.   

Abstract

The flavonoid silibinin, the main compound extracted from the milk thistle Silybum marianum, displays hepatoprotective properties in acute and chronic liver injury. To further elucidate the mechanisms by which it acts, we studied the effects of silibinin on different functions of isolated rat Kupffer cells, namely the formation of superoxide anion radical (02-), nitric oxide (NO), tumor necrosis factor alpha (TNF-alpha), prostaglandin E(2) (PGE(2)), and leukotriene B(4) (LTB(4)). Production of 02- and NO were inhibited in a dose-dependent manner, with an 50 percent inhibitory concentration (IC(50)) value around 80 micro mol/L. No effect on TNF-alpha formation was detected. Opposite effects were found on the cyclooxygenase and 5-lipoxygenase pathway of arachidonic acid metabolism. Whereas no influence on PGE(2) formation was observed with silibinin concentrations up to 100 micro mol/L, a strong inhibitory effect on LTB(4) formation became evident. The IC(50)-value for inhibiting the formation of this eicosanoid was determined to be 15 micro mol/L silibinin. The strong inhibition of LTB(4), formation by silibinin was confirmed in experiments with phagocytic cells isolated from human liver. Hence, while rather high concentrations of silibinin are necessary to diminish free radical formation by activated Kupffer cells, significant inhibition of the 5-lipoxygenase pathway already occurs at silibinin concentrations which are achieved in vivo. Selective inhibition of leukotriene formation by Kupffer cells can at least partly account for the hepatoprotective properties of silibinin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666328     DOI: 10.1053/jhep.1996.v23.pm0008666328

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

Review 1.  Silybin and the liver: from basic research to clinical practice.

Authors:  Carmela Loguercio; Davide Festi
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 2.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

3.  The effect of silymarin on hepatic regeneration after partial hepatectomy: is silymarin effective in hepatic regeneration?

Authors:  Suleyman Cetinkunar; Serhat Tokgoz; Bulent Caglar Bilgin; Hasan Erdem; Recep Aktimur; Serpil Can; Huseyin Serkan Erol; Atilla Isgoren; Selim Sozen; Yilmaz Polat
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.

Authors:  Khaled Khazim; Yves Gorin; Rita Cassia Cavaglieri; Hanna E Abboud; Paolo Fanti
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

Review 5.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

Review 6.  The use of silymarin in the treatment of liver diseases.

Authors:  R Saller; R Meier; R Brignoli
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Hepatoprotective effect of silymarin.

Authors:  Nancy Vargas-Mendoza; Eduardo Madrigal-Santillán; Angel Morales-González; Jaime Esquivel-Soto; Cesar Esquivel-Chirino; Manuel García-Luna Y González-Rubio; Juan A Gayosso-de-Lucio; José A Morales-González
Journal:  World J Hepatol       Date:  2014-03-27

Review 8.  Silymarin and epithelial cancer chemoprevention: how close we are to bedside?

Authors:  Manjinder Kaur; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-15       Impact factor: 4.219

9.  Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.

Authors:  Da-Hee Jeong; Gi-Ppeum Lee; Won-Il Jeong; Sun-Hee Do; Hai-Jie Yang; Dong-Wei Yuan; Ho-Yong Park; Kyu-Jong Kim; Kyu-Shik Jeong
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

10.  Silymarin protects against acute ethanol-induced hepatotoxicity in mice.

Authors:  Zhenyuan Song; Ion Deaciuc; Ming Song; David Y-W Lee; Yanze Liu; Xiaosheng Ji; Craig McClain
Journal:  Alcohol Clin Exp Res       Date:  2006-03       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.